ESMO 2022 | CAR-T in solid tumors: challenges and future directions

Jon Amund Kyte, MD, PhD, University of Oslo, Oslo, Norway, provides an overview of CAR T-cell therapies in the use of solid tumors and challenges associated with implementation, such as target antigens, tumor heterogeneity and immune suppression. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.